Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07835295 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

REMIfentanil (2 vs. 4 mcg/kg) Facilitated Intubation Without Neuromuscular Blockade Versus Succinylcholine and Rocuronium With Sugammadex for Endotracheal Intubation in Spine Surgery Requiring Motor Evoked Potential Monitoring

Name: REMIfentanil (2 vs. 4 mcg/kg) Facilitated Intubation Without Neuromuscular Blockade Versus Succinylcholine and Rocuronium With Sugammadex for Endotracheal Intubation in Spine Surgery Requiring Motor Evoked Potential Monitoring — clinical trial record (NCT07835295)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: REMI-MEP

StatusNot Yet Recruiting

PhasePhase 4

SponsorMayo Clinic

Started2026-09

View on ClinicalTrials.gov ↗

Mayo Clinic

1,015 trials monitored

See 115 trials at risk

The purpose of this research is to compare four commonly used anesthesia medication strategies for placing a breathing tube in patients undergoing spine surgery that requires motor evoked potential (MEP) monitoring.

Trial Details

NCT Number	NCT07835295
Lead Sponsor	Mayo Clinic
Conditions	Airway Management, Endotracheal Intubation
Enrollment	316 participants
Start Date	2026-09
Primary Completion	2028-09 (estimated)
Study Completion	2029-01 (estimated)
Updated on ClinicalTrials.gov	2026-09-22